Cargando…

Multi-Omics Analysis of MCM2 as a Promising Biomarker in Pan-Cancer

Minichromosome maintenance 2 (MCM2) is a member of the minichromosomal maintenance family of proteins that mainly regulates DNA replication and the cell cycle and is involved in regulating cancer cell proliferation in various cancers. Previous studies have reported that MCM2 plays a pivotal role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Jing, Lan, Hua, Huang, Dongqing, Guo, Xiaohui, Liu, Chu, Liu, Shuping, Zhang, Peng, Cheng, Yan, Xiao, Songshu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9174984/ https://www.ncbi.nlm.nih.gov/pubmed/35693940 http://dx.doi.org/10.3389/fcell.2022.852135

Ejemplares similares

Multi-Omics Analysis of the Therapeutic Value of MAL2 Based on Data Mining in Human Cancers
por: Yuan, Jing, et al.
Publicado: (2022)

Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis
por: Zhang, Chiyuan, et al.
Publicado: (2021)

Multi-Omics Uncover Neonatal Cecal Cell Development Potentials
por: Chen, Liang, et al.
Publicado: (2022)

MCM4 Is a Novel Biomarker Associated With Genomic Instability, BRCAness Phenotype, and Therapeutic Potentials in Soft-Tissue Sarcoma
por: Liu, Qi, et al.
Publicado: (2021)

Multi-Omics Prognostic Signatures Based on Lipid Metabolism for Colorectal Cancer
por: Sun, YuanLin, et al.
Publicado: (2022)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

Multi-Omics Characterizes the Effects and Mechanisms of CD1d in Nonalcoholic Fatty Liver Disease Development
por: Zheng, Qiuxian, et al.
Publicado: (2022)

Single Cell Multi-Omics Technology: Methodology and Application
por: Hu, Youjin, et al.
Publicado: (2018)

MCM3AP-AS1: An Indispensable Cancer-Related LncRNA
por: Yu, Xiao, et al.
Publicado: (2021)

Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
por: Chu, Guangdi, et al.
Publicado: (2021)

Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine
por: Tu, Can, et al.
Publicado: (2021)

Editorial: Multi-Omics Approaches to Study Placental Development and Disease
por: Tuteja, Geetu, et al.
Publicado: (2021)

Advances in Single-Cell Multi-Omics and Application in Cardiovascular Research
por: Zhang, Xingwu, et al.
Publicado: (2022)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

MCM5 Aggravates the HDAC1-Mediated Malignant Progression of Lung Cancer
por: Zhang, Lin-lin, et al.
Publicado: (2021)

Integrated Analysis of Multi-Omics Alteration, Immune Profile, and Pharmacological Landscape of Pyroptosis-Derived lncRNA Pairs in Gastric Cancer
por: Guo, Chunguang, et al.
Publicado: (2022)

Revealing Cavin-2 Gene Function in Lung Based on Multi-Omics Data Analysis Method
por: Li, Changsheng, et al.
Publicado: (2022)

Multi-Omics Data Integration Analysis of an Immune-Related Gene Signature in LGG Patients With Epilepsy
por: Cheng, Quan, et al.
Publicado: (2021)

Exploring the Mechanism of Action of Canmei Formula Against Colorectal Adenoma Through Multi-Omics Technique
por: Guo, Cui, et al.
Publicado: (2021)

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
por: Zhao, Qi, et al.
Publicado: (2021)

Colon Cancer-Related Genes Identification and Function Study Based on Single-Cell Multi-Omics Integration
por: Sun, Xuepu, et al.
Publicado: (2021)

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
por: Jia, Zeming, et al.
Publicado: (2022)

Editorial: Multi-omics data integration: key to thoroughly understanding the immune system
por: Jiménez, Cristina, et al.
Publicado: (2023)

Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
por: Abdelatty, Alaa, et al.
Publicado: (2022)

S100A8/A9 in Myocardial Infarction: A Promising Biomarker and Therapeutic Target
por: Cai, ZhuLan, et al.
Publicado: (2020)

Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2022)

Multi-Omics Signatures Identification for LUAD Prognosis Prediction Model Based on the Integrative Analysis of Immune and Hypoxia Signals
por: Lou, Yuqing, et al.
Publicado: (2022)

Multi-Omics Analysis of Acute Lymphoblastic Leukemia Identified the Methylation and Expression Differences Between BCP-ALL and T-ALL
por: Li, Jin-Fan, et al.
Publicado: (2021)

Identification of Pan-Cancer Biomarkers Based on the Gene Expression Profiles of Cancer Cell Lines
por: Ding, ShiJian, et al.
Publicado: (2021)

Pan-Cancer Methylated Dysregulation of Long Non-coding RNAs Reveals Epigenetic Biomarkers
por: Zhao, Ning, et al.
Publicado: (2022)

Histopathological Images and Multi-Omics Integration Predict Molecular Characteristics and Survival in Lung Adenocarcinoma
por: Chen, Linyan, et al.
Publicado: (2021)

Multi-omic analyses in immune cell development with lessons learned from T cell development
por: Cordes, Martijn, et al.
Publicado: (2023)

Multi-omics analysis explores the effect of chronic exercise on liver metabolic reprogramming in mice
por: Lu, Zhaoxu, et al.
Publicado: (2023)

Editorial: Pathogenic mechanisms in neurodevelopmental disorders: advances in cellular models and multi-omics approaches
por: Hollstein, R., et al.
Publicado: (2023)

Editorial: Omics Data Integration Towards Mining of Phenotype Specific Biomarkers in Cancers and Diseases
por: Cheng, Liang, et al.
Publicado: (2021)

Toll-Like Receptor 4 as a Favorable Prognostic Marker in Bladder Cancer: A Multi-Omics Analysis
por: Lu, Jun-Lin, et al.
Publicado: (2021)

Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States–Based Subtyping in Bladder Cancer
por: Hu, Rixin, et al.
Publicado: (2022)

Multi-Omic Approach to Identify Phenotypic Modifiers Underlying Cerebral Demyelination in X-Linked Adrenoleukodystrophy
por: Richmond, Phillip A., et al.
Publicado: (2020)

Integrated Multi-Omics Analysis Reveals the Effect of Maternal Gestational Diabetes on Fetal Mouse Hippocampi
por: Luo, Si-si, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h6r4quqbpk6qvirpq3qc3e4mne